Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology
Open Access
- 25 March 2015
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 19 (6) , 1284-1295
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative motor neuron disease which currently has no cure. Research using rodent ALS models transgenic for mutant superoxide dismutase 1 (SOD1) has implicated that glial-neuronal interactions play a major role in the destruction of motor neurons, but the generality of this mechanism is not clear as SOD1 mutations only account for less than 2% of all ALS cases. Recently, this hypothesis was backed up by observation of similar effects using astrocytes derived from post-mortem spinal cord tissue of ALS patients which did not carry SOD1 mutations. However, such necropsy samples may not be easy to obtain and may not always yield viable cell cultures. Here, we have analysed olfactory mucosa (OM) cells, which can be easily isolated from living ALS patients. Disease-specific changes observed when ALS OM cells were co-cultured with human spinal cord neurons included decreased neuronal viability, aberrant neuronal morphology and altered glial inflammatory responses. Our results show the potential of OM cells as new cell models for ALS.Keywords
Funding Information
- Spanish Ministry of Science (SAF2010-22106)
- Pedro LaínEntralgo (NDG07/6)
This publication has 83 references indexed in Scilit:
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyThe Lancet Neurology, 2012
- The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- Astrocytes from familial and sporadic ALS patients are toxic to motor neuronsNature Biotechnology, 2011
- Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse modelGlia, 2011
- Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALSNature Neuroscience, 2010
- Prevention of Senescence Progression in Reversibly Immortalized Human Ensheathing Glia Permits Their Survival After DeimmortalizationMolecular Therapy, 2010
- Extracellular mutant SOD1 induces microglial‐mediated motoneuron injuryGlia, 2009
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002